{"id":"https://openalex.org/W7224839942","doi":"https://doi.org/10.5281/zenodo.23799312","title":"AZTREONAM/AVIBACTAM (EMBLAVEO) FOR SERIOUS GRAM-NEGATIVE INFECTIONS: A CLINICAL REVIEW OF MECHANISM, PHARMACOKINETICS, CLINICAL TRIAL EVIDENCE, AND STEWARDSHIP CONSIDERATIONS","display_name":"AZTREONAM/AVIBACTAM (EMBLAVEO) FOR SERIOUS GRAM-NEGATIVE INFECTIONS: A CLINICAL REVIEW OF MECHANISM, PHARMACOKINETICS, CLINICAL TRIAL EVIDENCE, AND STEWARDSHIP CONSIDERATIONS","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7224839942","doi":"https://doi.org/10.5281/zenodo.23799312"},"language":"en","primary_location":{"id":"doi:10.5281/zenodo.23799312","doi":"https://doi.org/10.5281/zenodo.23799312","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23799312","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.5281/zenodo.23799312","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5160193706","display_name":"*Laigin Sebastian","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"*Laigin Sebastian","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5160193706"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.78262744,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.9663000106811523,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.9663000106811523,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.03020000085234642,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aztreonam-avibactam","display_name":"aztreonam-avibactam","score":0.9860000014305115},{"id":"https://openalex.org/keywords/metallo-beta-lactamase","display_name":"metallo-beta-lactamase","score":0.847000002861023},{"id":"https://openalex.org/keywords/carbapenem-resistance","display_name":"carbapenem resistance","score":0.7570000290870667},{"id":"https://openalex.org/keywords/gram-negative-infections","display_name":"gram-negative bacterial infection","score":0.8539999723434448},{"id":"https://openalex.org/keywords/complicated-intra-abdominal-infections","display_name":"complicated intra-abdominal infections","score":0.906000018119812},{"id":"https://openalex.org/keywords/monobactams","display_name":"monobactams","score":0.8119999766349792},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7129999995231628},{"id":"https://openalex.org/keywords/dosage","display_name":"dosage","score":0.4699999988079071},{"id":"https://openalex.org/keywords/antimicrobial-stewardship","display_name":"antimicrobial stewardship","score":0.8870000243186951},{"id":"https://openalex.org/keywords/meropenem","display_name":"meropenem","score":0.4690000116825104}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8003000020980835},{"id":"https://openalex.org/C2776040555","wikidata":"https://www.wikidata.org/wiki/Q19903321","display_name":"Antimicrobial stewardship","level":4,"score":0.7034000158309937},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.6826000213623047},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.6347000002861023},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.6114000082015991},{"id":"https://openalex.org/C2780416669","wikidata":"https://www.wikidata.org/wiki/Q418546","display_name":"Aztreonam","level":5,"score":0.6075999736785889},{"id":"https://openalex.org/C2779259085","wikidata":"https://www.wikidata.org/wiki/Q418946","display_name":"Colistin","level":3,"score":0.5460000038146973},{"id":"https://openalex.org/C2777406300","wikidata":"https://www.wikidata.org/wiki/Q15410251","display_name":"Avibactam","level":5,"score":0.5223000049591064},{"id":"https://openalex.org/C2775933652","wikidata":"https://www.wikidata.org/wiki/Q15410251","display_name":"Ceftazidime/avibactam","level":5,"score":0.5181000232696533},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.490200012922287},{"id":"https://openalex.org/C2779375183","wikidata":"https://www.wikidata.org/wiki/Q421670","display_name":"Meropenem","level":4,"score":0.4512999951839447},{"id":"https://openalex.org/C2777914695","wikidata":"https://www.wikidata.org/wiki/Q12192","display_name":"Pneumonia","level":2,"score":0.44600000977516174},{"id":"https://openalex.org/C502991105","wikidata":"https://www.wikidata.org/wiki/Q5133849","display_name":"Clinical research","level":2,"score":0.4009000062942505},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.3580999970436096},{"id":"https://openalex.org/C148482608","wikidata":"https://www.wikidata.org/wiki/Q17007018","display_name":"Clinical study design","level":3,"score":0.3449999988079071},{"id":"https://openalex.org/C4937899","wikidata":"https://www.wikidata.org/wiki/Q68541106","display_name":"Antimicrobial","level":2,"score":0.32420000433921814},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.30959999561309814},{"id":"https://openalex.org/C3019249092","wikidata":"https://www.wikidata.org/wiki/Q274493","display_name":"Antibacterial agent","level":3,"score":0.30250000953674316},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.29350000619888306},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.288100004196167},{"id":"https://openalex.org/C94665300","wikidata":"https://www.wikidata.org/wiki/Q63391344","display_name":"Antibiotic resistance","level":3,"score":0.2847000062465668},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.273499995470047},{"id":"https://openalex.org/C2777950569","wikidata":"https://www.wikidata.org/wiki/Q17021836","display_name":"Stewardship (theology)","level":3,"score":0.2623000144958496},{"id":"https://openalex.org/C63433958","wikidata":"https://www.wikidata.org/wiki/Q1774688","display_name":"Clinical pharmacology","level":2,"score":0.2538999915122986}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.5281/zenodo.23799312","doi":"https://doi.org/10.5281/zenodo.23799312","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23799312","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.5281/zenodo.23799313","doi":"https://doi.org/10.5281/zenodo.23799313","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23799313","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.5281/zenodo.23799312","doi":"https://doi.org/10.5281/zenodo.23799312","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23799312","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7223215984","https://openalex.org/W4416398304","https://openalex.org/W3193930247","https://openalex.org/W4410313452","https://openalex.org/W4387187170","https://openalex.org/W4389029085","https://openalex.org/W7162427479","https://openalex.org/W7162437066","https://openalex.org/W4414109457","https://openalex.org/W7154605780"],"abstract_inverted_index":{"Background:":[0],"Metallo-\u03b2-lactamase":[1],"(MBL)-producing":[2],"gram-negative":[3,361],"bacteria":[4],"hydrolyze":[5],"nearly":[6],"all":[7],"conventional":[8],"\u03b2-lactam":[9],"antibiotics,":[10],"including":[11],"carbapenems,":[12],"and":[13,73,101,104,112,121,177,215,289,332,355,386,395],"remain":[14],"outside":[15],"the":[16,60,109,117,122,203,221,231,257,299,318,342],"inhibitory":[17],"spectrum":[18],"of":[19,45,62,77,346],"currently":[20,375],"available":[21,287],"\u03b2-lactamase":[22],"inhibitors,":[23],"creating":[24],"a":[25,33,42,352],"major":[26],"therapeutic":[27],"gap.":[28],"Aztreonam/avibactam":[29,350],"(Emblaveo)":[30],"combines":[31],"aztreonam,":[32],"monobactam":[34],"intrinsically":[35],"stable":[36],"to":[37,49,188,380],"MBL":[38],"hydrolysis,":[39],"with":[40,154,158,239,266,280,285,313,382],"avibactam,":[41],"non-\u03b2-lactam":[43],"inhibitor":[44],"co-produced":[46],"serine":[47],"\u03b2-lactamases,":[48],"restore":[50],"antibacterial":[51],"activity":[52],"against":[53],"this":[54],"resistance":[55],"phenotype.":[56],"Objective:":[57],"To":[58],"review":[59,83],"mechanism":[61],"action,":[63],"pharmacokinetics,":[64],"pivotal":[65,110],"clinical":[66,82,198,273],"trial":[67,181,222,263],"evidence,":[68],"safety":[69],"profile,":[70],"dosing":[71,127],"considerations,":[72],"antimicrobial":[74,396],"stewardship":[75,397],"role":[76],"aztreonam/avibactam.":[78],"Methods:":[79],"A":[80],"narrative":[81],"was":[84,236,277,292],"conducted":[85],"using":[86],"PubMed/MEDLINE,":[87],"The":[88,130],"Lancet":[89],"Infectious":[90,95],"Diseases,":[91,96],"JAC-Antimicrobial":[92],"Resistance,":[93],"Clinical":[94],"current":[97,126],"FDA":[98,131],"approval":[99],"documentation":[100],"prescribing":[102],"information,":[103],"conference":[105],"proceedings,":[106],"focusing":[107],"on":[108,148,172],"REVISIT":[111,180,183,324],"ASSEMBLE":[113,262],"phase":[114,178,260],"3":[115,179,261],"trials,":[116],"REJUVENATE":[118],"pharmacokinetic":[119],"study,":[120],"dose-selection":[123],"literature":[124],"supporting":[125],"recommendations.":[128],"Results:":[129],"approved":[132,376],"aztreonam/avibactam":[133,189,240,281,314],"(a":[134],"fixed":[135],"3:1":[136],"aztreonam:avibactam":[137],"ratio,":[138],"supplied":[139],"as":[140],"1.5":[141],"g":[142,144],"aztreonam/0.5":[143],"avibactam":[145],"per":[146],"vial)":[147],"February":[149],"7,":[150],"2025,":[151],"in":[152,202,230,315,323],"combination":[153],"metronidazole,":[155],"for":[156,359,368],"adults":[157],"complicated":[159],"intra-abdominal":[160],"infection":[161],"(cIAI)":[162],"who":[163],"have":[164],"limited":[165,379],"or":[166],"no":[167],"alternative":[168,384],"treatment":[169],"options,":[170,385],"based":[171],"prior":[173],"aztreonam":[174],"efficacy/safety":[175],"data":[176],"results.":[182],"(422":[184],"patients":[185,265],"randomized":[186],"2:1":[187],"\u00b1":[190,194,245],"metronidazole":[191],"versus":[192,210,226,282,295],"meropenem":[193,244],"colistin)":[195],"found":[196],"comparable":[197,216],"cure":[199,274],"at":[200,275],"test-of-cure":[201,276],"cIAI":[204,381],"population":[205],"(76.4%,":[206],"95%":[207,212],"CI":[208,213],"70.3\u201381.8%,":[209],"74.0%,":[211],"65.0\u201381.7%)":[214],"28-day":[217,290],"all-cause":[218],"mortality":[219,229,291],"across":[220,337],"overall":[223],"(4%":[224],"[12/282]":[225],"7%":[227],"[10/140]);":[228],"hospital-acquired/ventilator-associated":[232],"pneumonia":[233],"(HAP/VAP)":[234],"subgroup":[235],"numerically":[237],"lower":[238],"(11%":[241],"[8/74])":[242],"than":[243],"colistin":[246],"(19%":[247],"[7/36]),":[248],"though":[249,298,373],"HAP/VAP":[250],"is":[251,378],"not":[252],"an":[253],"FDA-approved":[254],"indication.":[255],"In":[256],"dedicated":[258],"MBL-focused":[259],"(15":[264],"confirmed":[267],"MBL-producing":[268,366],"pathogens,":[269],"predominantly":[270],"NDM-1/NDM-5/VIM-2/L1":[271],"subtypes),":[272],"42%":[278],"(5/12)":[279],"0%":[283],"(0/3)":[284],"best":[286],"therapy,":[288],"8%":[293],"(1/12)":[294],"33%":[296],"(1/3),":[297],"small":[300],"sample":[301],"size":[302],"precludes":[303],"definitive":[304],"statistical":[305],"inference.":[306],"No":[307],"treatment-related":[308],"serious":[309],"adverse":[310,321],"events":[311],"occurred":[312],"either":[316],"trial;":[317],"most":[319],"common":[320],"reactions":[322],"were":[325],"hepatic":[326],"transaminase":[327],"elevation,":[328],"anemia,":[329],"diarrhea,":[330],"hypokalemia,":[331],"pyrexia.":[333],"Dosing":[334],"requires":[335,389],"adjustment":[336],"renal":[338,344],"function":[339],"strata,":[340],"reflecting":[341],"substantially":[343],"elimination":[345],"both":[347],"components.":[348],"Conclusion:":[349],"represents":[351],"mechanistically":[353],"distinct":[354],"clinically":[356],"validated":[357],"option":[358],"difficult-to-treat":[360],"infections,":[362],"particularly":[363],"those":[364],"involving":[365],"organisms":[367],"which":[369],"few":[370],"alternatives":[371],"exist,":[372],"its":[374],"indication":[377],"limited/no":[383],"appropriate":[387],"use":[388],"accurate":[390],"microbiological":[391],"diagnosis,":[392],"renal-function-based":[393],"dosing,":[394],"oversight.":[398]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-31T00:00:00"}